Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Non-Current Assets (2017 - 2022)

Historic Non-Current Assets for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $4.9 million.

  • Iterum Therapeutics' Non-Current Assets fell 4022.1% to $4.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $4.9 million, marking a year-over-year decrease of 4022.1%. This contributed to the annual value of $8.2 million for FY2021, which is 2612.9% down from last year.
  • As of Q3 2022, Iterum Therapeutics' Non-Current Assets stood at $4.9 million, which was down 4022.1% from $5.7 million recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Non-Current Assets ranged from a high of $14.1 million in Q3 2020 and a low of $3.8 million during Q2 2018
  • In the last 5 years, Iterum Therapeutics' Non-Current Assets had a median value of $10.2 million in 2021 and averaged $9.6 million.
  • Per our database at Business Quant, Iterum Therapeutics' Non-Current Assets skyrocketed by 25404.24% in 2019 and then tumbled by 4241.78% in 2021.
  • Quarter analysis of 5 years shows Iterum Therapeutics' Non-Current Assets stood at $4.8 million in 2018, then surged by 190.5% to $14.0 million in 2019, then decreased by 20.76% to $11.1 million in 2020, then dropped by 26.13% to $8.2 million in 2021, then tumbled by 40.47% to $4.9 million in 2022.
  • Its Non-Current Assets was $4.9 million in Q3 2022, compared to $5.7 million in Q2 2022 and $7.6 million in Q1 2022.